Publications:

Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Cells

Smorodinsky-Atias, Karina K; Soudah, Nadine N; Engelberg, David D

Publication Date: 2020-01-06

Variant appearance in text: ERK1: Y53H

PubMed Link: 31935908

Variant Present in the following documents:

• Main text
• cells-09-00129.pdf

View BVdb publication page

Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial-Mesenchymal Transition in Cancer.

International Journal Of Molecular Sciences

Olea-Flores, Monserrat M; Zuñiga-Eulogio, Miriam Daniela MD; Mendoza-Catalán, Miguel Angel MA; Rodríguez-Ruiz, Hugo Alberto HA; Castañeda-Saucedo, Eduardo E; Ortuño-Pineda, Carlos C; Padilla-Benavides, Teresita T; Navarro-Tito, Napoleón N

Publication Date: 2019-06-13

Variant appearance in text: ERK1: Tyr53His

PubMed Link: 31200510

Variant Present in the following documents:

• Main text
• ijms-20-02885.pdf

View BVdb publication page

ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.

Cancer Research

Goetz, Eva M EM; Ghandi, Mahmoud M; Treacy, Daniel J DJ; Wagle, Nikhil N; Garraway, Levi A LA

Publication Date: 2014-12-01

Variant appearance in text: ERK1: Y53H

PubMed Link: 25320010

Variant Present in the following documents:

• Main text

View BVdb publication page